Eye drops to replace painful injections in AMD patients

By Flora Southey

The University of Birmingham has developed a cell-penetrating peptide it claims could be used to make eye drop versions of age-related macular degeneration drugs currently delivered by injection.

Drugging the 'undruggable'

Drugging the 'undruggable'

By Mike Nagle

Over 50 per cent of proteins in the body are considered too
difficult to target with drugs; they are 'undruggable'. Yet it is
exactly these molecules US pharma firm Avalon is focussing on.

Amgen CFO walks away

Amgen CFO walks away

By Emilie Reymond

Amgen is seeing its chief financial officer (CFO) walk away while
the Californian biotech giant tries to heal its wounds after a
difficult year.


Follow us


Featured Suppliers